Carriage of Class 1 and 2 Integrons in Quinolone, Extended-Spectrum-β-Lactamase-Producing and Multi Drug Resistant E.coli and K.pneumoniae: High Burden of Antibiotic Resistance

Froogh Shams ^1,2, Alka Hasani ^1,2 * , Mohammad Ahangarzadeh Rezaee ², Mohammad Reza Nahaie ², Akbar Hasani ³, Mohammad Hossein Soroush Bar Haghi ², Ali Pormohammad ^1,2, Asghar Elli Arbatan ⁴

Cited by CrossRef: 12

1- Barzegar S, Arzanlou M, Teimourpour A, Esmaelizad M, Yousefipour M, MohammadShahi J, Teimourpour R. Prevalence of the Integrons and ESBL Genes in Multidrug-Resistant Strains of Escherichia coli Isolated from Urinary Tract Infections, Ardabil, Iran. Iran J Med Microbiol. 2022;16(1):56 [Crossref]

2- Tateda K, Ohno A, Ishii Y, Murakami H, Yamaguchi K. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: A longitudinal analysis from 1994 to 2016. Journal of Infection and Chemotherapy. 2019;25(8):594 [Crossref]

3- Lv Y, Xu J, Xu K, Liu X, Guo X, Lu S, Xi B. Accumulation characteristics and biological response of ginger to sulfamethoxazole and ofloxacin. Environmental Pollution. 2020;262:114203 [Crossref]

4- Charnock C, Samuelsen Ø, Nordlie A, Hjeltnes B. Use of a Commercially Available Microarray to Characterize Antibiotic-Resistant Clinical Isolates of Klebsiella pneumoniae . Curr Microbiol. 2018;75(2):163 [Crossref]

5- Ali M, AL-Nuaeyme H. Typing and Integron Distribution among Multi-Drug Resistance Escherichia coli. J Res Appl Sci Biotechnol. 2024;3(1):232 [Crossref]

6- Hadifar S, Moghoofei M, Nematollahi S, Ramazanzadeh R, Sedighi M, Salehi-Abargouei A, Miri A. Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis. Jpn J Infect Dis. 2017;70(1):19 [Crossref]

7- Rozwadowski M, Gawel D. Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic Escherichia coli—An Update. Genes. 2022;13(8):1397 [Crossref]

8- Lambrecht E, Van Meervenne E, Boon N, Van de Wiele T, Wattiau P, Herman L, Heyndrickx M, Van Coillie E. Characterization of Cefotaxime- and Ciprofloxacin-Resistant CommensalEscherichia coliOriginating from Belgian Farm Animals Indicates High Antibiotic Resistance Transfer Rates. Microbial Drug Resistance. 2018;24(6):707 [Crossref]

9- Najafgholizadeh Pirzaman A, Mojtahedi A. Investigation of antibiotic resistance and the presence of integron genes among ESBL producing Klebsiella isolates. Meta Gene. 2019;19:37 [Crossref]

10- Athanasakopoulou Z, Diezel C, Braun S, Sofia M, Giannakopoulos A, Monecke S, Gary D, Krähmer D, Chatzopoulos D, Touloudi A, Birtsas P, Palli M, Georgakopoulos G, Spyrou V, Petinaki E, Ehricht R, Billinis C. Occurrence and Characteristics of ESBL- and Carbapenemase- Producing Escherichia coli from Wild and Feral Birds in Greece. Microorganisms. 2022;10(6):1217 [Crossref]

11- Dhara L, Tripathi A. The use of eugenol in combination with cefotaxime and ciprofloxacin to combat ESBL‐producing quinolone‐resistant pathogenicEnterobacteriaceae. J Appl Microbiol. 2020;129(6):1566 [Crossref]